Catalent Inc (CTLT)
56.23
-0.18
(-0.32%)
USD |
NYSE |
Jun 28, 16:00
56.17
-0.06
(-0.11%)
After-Hours: 20:00
Catalent Cash from Operations (Quarterly): 12.00M for March 31, 2024
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 12.00M |
December 31, 2023 | 112.00M |
September 30, 2023 | -70.00M |
June 30, 2023 | 196.00M |
March 31, 2023 | -64.00M |
December 31, 2022 | 214.00M |
September 30, 2022 | -92.00M |
June 30, 2022 | 69.00M |
March 31, 2022 | 138.00M |
December 31, 2021 | 69.00M |
September 30, 2021 | 163.00M |
June 30, 2021 | 134.00M |
March 31, 2021 | 75.00M |
December 31, 2020 | 74.00M |
September 30, 2020 | 150.00M |
June 30, 2020 | 172.40M |
March 31, 2020 | 121.70M |
December 31, 2019 | 120.70M |
September 30, 2019 | 25.20M |
June 30, 2019 | 88.20M |
March 31, 2019 | 75.30M |
December 31, 2018 | 43.30M |
September 30, 2018 | 41.20M |
June 30, 2018 | 103.30M |
Date | Value |
---|---|
March 31, 2018 | 95.20M |
December 31, 2017 | 92.30M |
September 30, 2017 | 83.70M |
June 30, 2017 | 100.20M |
March 31, 2017 | 103.30M |
December 31, 2016 | 47.70M |
September 30, 2016 | 48.30M |
June 30, 2016 | 33.90M |
March 31, 2016 | 49.90M |
December 31, 2015 | 26.60M |
September 30, 2015 | 44.90M |
June 30, 2015 | 77.10M |
March 31, 2015 | 94.30M |
December 31, 2014 | 40.20M |
September 30, 2014 | -39.80M |
June 30, 2014 | 85.00M |
March 31, 2014 | 52.90M |
December 31, 2013 | 15.20M |
September 30, 2013 | 25.20M |
June 30, 2013 | 54.50M |
March 31, 2013 | 57.50M |
December 31, 2012 | 13.60M |
September 30, 2012 | 12.10M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-92.00M
Minimum
Sep 2022
214.00M
Maximum
Dec 2022
85.41M
Average
100.10M
Median
Cash from Operations (Quarterly) Benchmarks
Eli Lilly and Co | 1.166B |
Align Technology Inc | 28.66M |
Amgen Inc | 689.00M |
Gilead Sciences Inc | 2.219B |
Johnson & Johnson | 3.657B |
Cash from Operations (Quarterly) Related Metrics
Cash from Investing (Quarterly) | -74.00M |
Free Cash Flow | -123.00M |
Free Cash Flow Per Share (Quarterly) | -0.3407 |
Free Cash Flow to Equity (Quarterly) | -37.00M |
Free Cash Flow to Firm (Quarterly) | 14.34M |
Free Cash Flow Yield | -1.20% |